Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination

The increasing effectiveness of new disease-modifying drugs that suppress disease activity in multiple sclerosis has opened up opportunities for regenerative medicines that enhance remyelination and potentially slow disease progression. Although several new targets for therapeutic enhancement of rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Yasir A, Baer, Alexandra, Hofer, Matthias P, González, Ginez A, Rundle, Jon, Myrta, Szymon, Huang, Jeffrey K, Zhao, Chao, Rossner, Moritz J, Trotter, Matthew W B, Lubec, Gert, Franklin, Robin J M, Kotter, Mark R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons 2013
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914530/
https://www.ncbi.nlm.nih.gov/pubmed/24293318
http://dx.doi.org/10.1002/emmm.201303123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914530/
https://www.ncbi.nlm.nih.gov/pubmed/24293318
http://dx.doi.org/10.1002/emmm.201303123

Ejemplares similares